Modified polynucleotides for the production of biologics and proteins associated with human disease

US8999380B2 · kind B2 · utility

Assignee

• Moderna Therapeutics, Inc. · US

Inventors

• Stephane Bancel · Cambridge, US
• Tirtha Chakraborty · Medford, US
• Antonin de Fougerolles · Waterloo, BE
• Sayda M. Elbashir · Cambridge, US
• Matthias John · Hallstadt, DE
• Atanu Roy · Stoneham, US
• Susan Whoriskey · Belmont, US
• Kristy M. Wood · Wellesley, US
• Paul Hatala · Boston, US
• Jason P. Schrum · Philadelphia, US
• Kenechi Ejebe · New York, US
• Jeff Lynn Ellsworth · Lexington, US
• Justin Guild · Framingham, US

Key dates

• Filing date: Mar 9, 2013
• Grant date: Apr 7, 2015
• Expiry date: May 2, 2033

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.